Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank

NCT05392881 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT05392881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05392881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank
Lead sponsor
University of Kansas Medical Center
Phase
Observational
Overall status
Recruiting
Start date
August 9, 2021
Completion date
March 1, 2032
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypersensitivity pneumonitis, idiopathic pulmonary fibrosis, interstitial lung disease, pulmonary fibrosis, sarcoidosis